Skip to main content
Move the World.
Uganda Begins Massive New Ebola Vaccine Study

The Ebola outbreak in the northeastern provinces of the Democratic Republic of the Congo continues to rage. It is now the second deadliest outbreak on record, behind only the West African outbreak in 2014. The epicenter is in North Kivu, a conflict-torn province which shares borders with Rwanda and Uganda.

In June, a small number of Ugandan Ebola cases were the first to cross borders from the current Congo outbreak. The country will now play host a massive trial study of a new Ebola vaccine.

A New Weapon in the War on Ebola

A vaccine made by American pharmaceutical company Merck is already being used in Congo, with promising results. The vaccine is being used in outbreak control, in a method known as “ring vaccination.”

Ring vaccination works by encircling and cutting of the virus’s path of transmission; think firefighters clearing brush ahead of a wildfire to rob it of fuel. When a confirmed case of Ebola is found, epidemiologists trace whoever came into contact with that person.The people who contacted the Ebola patient (and then those who contacted them) are vaccinated in expanding rings until the virus is stopped in its tracks.

As confirmed cases continue to swell and the situation risks spiraling even further out of control, the World Health Organization (WHO) has made Merck’s vaccine available to ever broader circles. This comes with a catch, however: there is a finite supply of the Merck vaccine, and making more takes money and time. Congolese officials are also opposed to field testing another vaccine, concerned that it would complicate the outbreak response.

Enter Uganda

The Uganda trial will be testing a two-step vaccine — known as a “prime-boost” vaccine — made by Janssen Vaccines and Prevention. The first dose “primes” the immune system with antigen DNA; the second one, given 56 days later, “boosts” it with more antigen protein. Because it uses multiple methods to stimulate production of antibodies, it is thought to be more effective than traditional vaccination strategies.

According to the London School of Hygiene and Tropical Medicine (LSHTM), which is sponsoring the study, scientists will attempt to vaccinate 800 health workers and frontline responders — burial teams, ambulance drivers, cleaners — who are most at risk of becoming infected. These subjects will be studied for two years to determine how well the vaccine protects against Ebola and how long that protection lasts. 

If the vaccine proves not only effective but long-lasting, it could take the pressure off using only one source of vaccine and be more effective in closing the rings.

Information will also be gathered about the attitudes and perceptions towards the vaccines. This social study will be crucial for saving lives.

The Cold Water

Vaccines and antivirals are already working well in the DRC, but outbreak response has been whipsawed by the various armed groups active in the region and the mistrust and anger some have directed at healthcare workers.

North Kivu has long been unstable, host to an alphabet soup of bad actors that have in turn fostered the growth of powerful local protection militias, known by the catch-all name Mai-Mai. Such is the power of the Mai-Mai that even Congolese national forces  do not enter their territory.

When Ebola is traced to a place of Mai-Mai control, responders must be able to negotiate with their generals. Doing so correctly not only makes the response safer but more effective; the general has the power to ensure his whole village follows safe Ebola protocols and gets vaccinated.

 But years of corruption and violence makes trusting the responders, who take away their loved ones, deny families the funeral rites their deceased require, and appear ghoulish in their masked protective equipment, difficult. Ebola treatment centers have been attacked and burned, and healthcare workers are sometimes kidnapped and even killed.

Getting the vaccine to the people who need it in these conditions remains the greatest challenge; even if the Ugandan vaccine proves highly effective, that means little if it cannot be used. Ultimately, the data gathered in Uganda about perceptions and attitudes towards the vaccines may prove to be the most important part of the study.

Ed. note: This piece has been updated from an earlier draft.

Stay up to date

Up Next

Biohacking
Biohacker’s Prosthetic Arm Lets Him Play a Synthesizer With His Mind
Biohacker’s Prosthetic Arm Lets Him Play a Synthesizer With His Mind
Biohacking
Biohacker’s Prosthetic Arm Lets Him Play a Synthesizer With His Mind
Biohacker Bertolt Meyer has built the SynLimb, a controller that attaches to his prosthetic arm, allowing him to control his modular synthesizer with his mind.

Biohacker Bertolt Meyer has built the SynLimb, a controller that attaches to his prosthetic arm, allowing him to control his modular synthesizer with his mind.

Medicine
RNA Vaccines Could Change Everything in the Fight Against Disease
RNA Vaccines Could Change Everything in the Fight Against Disease
Medicine
RNA Vaccines Could Change Everything in the Fight Against Disease
Traditional methods of vaccination have come up against difficult challenges. They can also be expensive and time-consuming to produce. New RNA vaccines are faster, cheaper, and safer, and show great potential to meet evolving threats.

Traditional methods of vaccination have come up against difficult challenges. They can also be expensive and time-consuming to produce, curtailing efforts to control outbreaks or head off a flu season caused by an unexpected strain. A newer type of vaccines, using RNA, could alleviate these issues. Faster, cheaper, and safer, RNA vaccines show great potential to meet evolving threats.

Superhuman
How 3D-Printing Is Revolutionizing Heart Surgery
How 3D-Printing Is Revolutionizing Heart Surgery
Watch Now
Superhuman
How 3D-Printing Is Revolutionizing Heart Surgery
When a young boy was facing a complicated and dangerous heart operation, his doctors created an exact model of his heart to plan the surgery. And it probably saved his life.
Watch Now

Joseph had one of the most complicated heart conditions his doctors had ever seen. He faced a long and dangerous operation or a heart transplant. Without either, he wouldn't survive. Opting for surgery, Dr. Petros Anagnostopoulos at the American Family Children's Hospital prepped like few have ever done. He and his team 3D-printed a copy of Joseph's heart that they could explore and understand. It was another step forward...

On The Fringe
Can Snot Help Stop the Flu?
Can Snot Help Stop the Flu?
Watch Now
On The Fringe
Can Snot Help Stop the Flu?
The flu is a really tough target. The virus evolves far too fast to really pin it down. If only they could slow it...
Watch Now

The flu is a really tough target. The virus evolves far too fast to really pin it down. If only they could slow it down. That seemed pretty much impossible until two researchers had a breakthrough that involved the mucus of cancer patients. And what they found could fundamentally change our perception of not only the flu, but evolution itself.

Superhuman
Stem Cells Give Paralyzed Man Movement
Stem Cells Give Paralyzed Man Movement
Watch Now
Superhuman
Stem Cells Give Paralyzed Man Movement
Could an injection of embryonic stem cells into the spinal cord reverse paralysis?
Watch Now

After a devastating car accident, Lucas Lindner was left almost completely paralyzed. But an injection of embryonic stem cells in his spinal cord has given him back almost complete function of his arms and hands.

This Computer Can Write 2,000 Snarky Articles Per Second
This Computer Can Write 2,000 Snarky Articles Per Second
This Computer Can Write 2,000 Snarky Articles Per Second
What does it mean for the future of journalism when a computer can turn mounds of data into a cohesive narrative?
By Mike Riggs

What does it mean for the future of journalism when a computer can turn mounds of data into a cohesive narrative?

Can Tech Giants Get Ahead of A.I.?
Can Tech Giants Get Ahead of A.I.?
Can Tech Giants Get Ahead of A.I.?
Companies gather to discuss impact of A.I. A possible neural lace breakthrough. And unmanned cargo ships. This is...
By Mike Riggs

Companies gather to discuss impact of A.I. A possible neural lace breakthrough. And unmanned cargo ships. This is the coolest stuff we've read this week.

Superhuman
The Promise of Gene Therapy
The Promise of Gene Therapy
Watch Now
Superhuman
The Promise of Gene Therapy
When Karen was told her daughter had an incurable disease, she started a gene therapy company to find a cure.
Watch Now

When doctors told Karen there was no cure for her daughter’s brain disease, she took matters into her own hands. With no scientific background, she created a gene therapy business that can fix the faulty genes in patients like her daughter. Now she’s racing against the clock to extend her daughter’s life and improve the lives of others.

Superhuman
Superhuman Trailer
Superhuman Trailer
Watch Now
Superhuman
Superhuman Trailer
Join us as we meet the innovators building our superhuman future.
Watch Now

Superhuman is a Freethink original series about the amazing advances in medical innovation that are making the present look more like a sci-fi depiction of the future. Join us as we meet the engineers, entrepreneurs, doctors and patients who are giving people a new lease on life today, while building our superhuman future of tomorrow.